Lux Biosciences, Inc. - Management

Manfred Zoltobrocki, Ph.D.

Managing Director,
Lux Biosciences GmbH, Frankfurt, Germany

Dr. Zoltobrocki is the Managing Director of Lux Biosciences GmbH. Dr. Zoltobrocki brings 34 years of experience from the pharmaceutical and biotechnology industries, where he held various positions in R&D and general management.

Prior to joining Lux Biosciences, Dr. Zoltobrocki served as CEO of EPIDAUROS Biotechnologie AG, a pharmacogenetics company, from 2003 until March 2006, where he managed the turnaround and a strategic reorientation.

Between 1996 and 2002, Dr. Zoltobrocki served as Vice President of Development at Aventis Pharma, where he directed the drug development units located in Germany including therapeutic areas like metabolism, infectious diseases, neurology, cardiology, and others. Prior to that, he held various positions in R&D management with the Aventis predecessor companies Hoechst Marion Roussel and Hoechst Pharma.

Dr. Zoltobrocki received his Ph.D. in biochemistry from the University of Frankfurt am Main, and spent 2 years as a post-doctoral fellow at the University of Iowa in the field of protein chemistry.